Shenzhen, China

Ao Chen

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ao Chen

Introduction

Ao Chen is a prominent inventor based in Shenzhen, China, known for his significant contributions to the field of nucleic acid sequencing. With a total of eight patents to his name, Chen has made remarkable advancements that enhance the efficiency and accuracy of sequencing technologies.

Latest Patents

Among his latest patents is a method for sequencing long-fragment nucleic acid. This innovative approach involves constructing a sequencing library using nucleic acid molecules that contain a long insert, along with first and second sequencing adapters. The sequencing is performed in segments, allowing for the effective sequencing of nucleic acids with long inserts. Another notable patent is a method for sequencing polynucleotides, which provides a technique for detecting the sequential incorporation of different nucleotides using the same light-emitting signal. This method achieves the determination of polynucleotide sequences with improved precision.

Career Highlights

Throughout his career, Ao Chen has worked with leading companies in the biotechnology sector, including BGI Shenzhen and MGI Tech Co., Ltd. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Wenwei Zhang and Erkai Liu, who have also made significant contributions to the field of biotechnology. Their collaborative efforts have further advanced the understanding and application of nucleic acid sequencing technologies.

Conclusion

Ao Chen's innovative work in nucleic acid sequencing has positioned him as a key figure in the biotechnology industry. His patents reflect a commitment to enhancing sequencing methods, which will undoubtedly have a lasting impact on research and medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…